Clinical Trial

An Investigational Study Examining the Cross-Validation of QbMobile in ADHD and Normative Populations

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The purpose of this study is to investigate QbMobile ability to collect and provide accurate and objective data which can be used to facilitate assessment and treatment procedures for ADHD in a clinical setting as well as remotely.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-10-22; most recent amendment 2026-05-04.
Trial Details
NCT Number NCT07220330
Lead Sponsor Qbtech AB
Conditions No History of ADHD, Attention Deficit Hyperactivity Disorder (ADHD), Healthy Volunteer
Enrollment 700 participants
Start Date 2025-01-15
Primary Completion 2026-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-05-06